FB2026_03 , released September 17, 2026
Reference Report
Open Close
Reference
Citation
Lanman, T.A., Bakar, D., Badders, N.M., Burke, A., Kokkinis, A., Shrader, J.A., Joe, G.O., Schindler, A.B., Bott, L.C., Harmison, G.G., Taylor, J.P., Fischbeck, K.H., Grunseich, C. (2016). Sexual Reassignment Fails to Prevent Kennedy's Disease.  J. Neuromuscul. Dis. 3(1): 121--125.
FlyBase ID
FBrf0250869
Publication Type
Research paper
Abstract
Spinal and bulbar muscular atrophy is caused by polyglutamine expansion in the androgen receptor. As an X-linked disease dependent on androgens, symptoms and findings are only fully manifest in males. Here we describe a 40-year-old male-to-female transgender SBMA patient who developed full disease manifestations despite undetectable levels of androgens. We used cell culture and animal models to show that spironolactone, the anti-androgen she had taken for 15 years, promotes nuclear localization and toxicity of the mutant protein, which may explain the disease manifestations in this patient.
PubMed ID
PubMed Central ID
PMC10427994 (PMC) (EuropePMC)
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    J. Neuromuscul. Dis.
    Title
    Journal of neuromuscular diseases
    ISBN/ISSN
    2214-3599 2214-3602
    Data From Reference
    Chemicals (1)